Paving the Potholes in Advocacy We’ve all been there. You’re navigating a complex system—whether it’s healthcare, education, or government—and you hit a wall. You find yourself asking: That frustration is...
Today brings exciting news for the rare disease community, born from immense effort, patient advocacy, and a refusal to back down. In a historic move, Metachromatic Leukodystrophy (MLD) and Duchenne...
